2Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe [J]. Lancet, 2005,366(9491):1079-1084. 被引量：1
3McDonald L C, Killgore G E, Thompson A, et al. An epidemic, toxin genevariant strain of Clostridium difficile [J]. N Engl J Med, 2005, 353(23):2433-2441. 被引量：1
4Drudy D, Harnedy N, Fanning S,et al. Isolation and characterization of toxin Anegative, toxin Bpositive Clostridium difficile in Dublin, Ireland [J]. Clin Microbiol Infect, 2007,13(3): 298 -304. 被引量：1
5Shin B M, Kuak E Y, Yoo S J, et al. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea [J]. Diagn Microbiol Infect Dis, 2008,60(4):333-337. 被引量：1
6Gerber M, Walch C, Lffler B, et al. Effect of subMIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile[J]. J Med Microbiol, 2008(Pt 6),57:776-783. 被引量：1
7Govind R, Dupuy B. Secretion of Clostridium difficile toxins A and B requires the holinlike protein TcdE[J]. PLoS Pathog, 2012,8(6):e1002727. 被引量：1
8Hawkey P M, Marriott C, Liu W E, et al. Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia ? [J]. J Clin Microbiol, 2013,51(10):3308-3313. 被引量：1
9Huang H, Wu S, Wang M, et al. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes [J]. Int J Antimicrob Agents, 2009, 33(4): 339-342. 被引量：1
10Martin H, Willey B, Low D E, et al, Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006 [J]. J Clin Microbiol, 2008, 46(9): 2999-3004. 被引量：1
